2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Benign Monoclonal Gammopathies in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Luisi, A | 1 |
| Binetti, L | 1 |
| Ria, R | 1 |
| Ruggieri, S | 1 |
| Berardi, S | 1 |
| Catacchio, I | 1 |
| Racanelli, V | 1 |
| Pavone, V | 1 |
| Rossini, B | 1 |
| Vacca, A | 1 |
| Ribatti, D | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
Topics: Aged; Androstadienes; Angiogenic Proteins; Animals; Bone Marrow; Bone Marrow Cells; Capillaries; Cel | 2013 |